Exclusive

Publication

Byline

Singapore Clinical Trial: Role of glucagon-like peptide 1 receptor Agonist (GLP1 RA) Dulaglutide on cerebral hemodynamics In patients with severe and symptomAtic steNosis of inTracranial internal carotid artery or middle cerebral artery with impaired cerebral vasodilatory reserve- an open-label randomised clinical trial (RADIANT)

Singapore, April 19 -- The Health Sciences Authority received information related to the study titled 'Role of glucagon-like peptide 1 receptor Agonist (GLP1 RA) Dulaglutide on cerebral hemodynamics I... Read More


Singapore Clinical Trial: A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Singapore, April 19 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the eff... Read More


Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 19 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 19 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 19 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


- आपसी मतभेद से अलग रह रहे दंपतियों को कराया समझौता

औरैया, अप्रैल 19 -- औरैया, संवाददाता। पुलिस अधीक्षक के निर्देश पर शनिवार को महिला थाना ककोर में 'प्रोजेक्ट नई किरण' के तहत विशेष काउंसलिंग सत्र आयोजित किया गया। महिला थाना प्रभारी की अध्यक्षता में आयो... Read More


मजदूर के नाम पर फर्म खोल करोड़ों का लेनदेन, मुकदमा दर्ज

सोनभद्र, अप्रैल 19 -- सोनभद्र, संवाददाता। रॉबर्ट्सगंज कोतवाली क्षेत्र में एक गरीब मजदूर के नाम पर फर्जी फर्म खोलकर करोड़ों रुपये का लेनदेन करने, जीएसटी व आयकर चोरी करने तथा धमकी देने का मामला सामने आया... Read More


म्योरपुर में बिजली आपूर्ति बेपटरी, उपभोक्ताओं में आक्रोश

सोनभद्र, अप्रैल 19 -- म्योरपुर,हिंदुस्तान संवाद। म्योरपुर क्षेत्र में बिजली आपूर्ति पूरी तरह से चरमरा गई है, जिससे उपभोक्ताओं में भारी आक्रोश है। अघोषित कटौती, लो-वोल्टेज और बार-बार होने वाले फॉल्ट के... Read More


'No AI in film': After row over AI babies in Hai Jawani Toh Ishq Hona Hai first look, Varun Dhawan film's team responds

India, April 19 -- Filmmaker David Dhawan is all set to reunite with his son Varun Dhawan for a romantic comedy, Hai Jawani Toh Ishq Hona Hai. Recently, the makers released the first look of the film,... Read More


Maha: 34 tribal girls reported missing in six months in Yavatmal district ; trafficking allegations surface

Yavatmal, April 19 -- As many as 34 tribal girls have reportedly gone missing over the past six months from Ralegaon taluka in Maharashtra's Yavatmal district, raising serious concerns and triggering ... Read More